Matrix Capital Management Company LP - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-01-02
4:10 pm
Sale
2025-12-3013DZentalis Pharmaceuticals, Inc.
ZNTL
Matrix Capital Management Company LP0
0.000%
-6,459,973decrease
(Position Closed)
Filing
History
2025-12-15
5:16 pm
Purchase
2025-12-1513DZentalis Pharmaceuticals, Inc.
ZNTL
Matrix Capital Management Company LP6,459,973
9.980%
6,459,973increase
(New Position)
Filing
History
2025-11-13
4:10 pm
Sale
2025-09-3013GMaze Therapeutics, Inc.
MAZE
Matrix Capital Management Company LP1,653,684
3.500%
-832,500decrease
(-33.49%)
Filing
History
2025-05-19
4:35 pm
Purchase
2025-05-1613DAura Biosciences, Inc.
AURA
Matrix Capital Management Company LP6,922,870
11.170%
6,922,870increase
(New Position)
Filing
History
2025-05-14
4:10 pm
Purchase
2025-03-3113GMaze Therapeutics, Inc.
MAZE
Matrix Capital Management Company LP2,486,184
5.700%
2,486,184increase
(New Position)
Filing
History
2025-04-07
4:15 pm
Unchanged
2025-03-3113GAltair Engineering Inc.
ALTR
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
History
2025-02-12
5:00 pm
Purchase
2024-12-3113GPerimeter Solutions, S.A.
PRM
Matrix Capital Management Company LP6,554,000
4.480%
6,554,000increase
(New Position)
Filing
History
2025-01-08
10:30 am
Sale
2024-12-3113GAdaptimmune Therapeutics plc
ADAPY
Matrix Capital Management Company LP0
0.000%
-135,000,000decrease
(Position Closed)
Filing
History
2024-12-05
5:17 pm
Purchase
2024-11-3013GAdaptimmune Therapeutics plc
ADAPY
Matrix Capital Management Company LP135,000,000
8.800%
135,000,000increase
(New Position)
Filing
History
2024-11-13
09:09 am
Unchanged
2024-11-1313GAltair Engineering Inc.
ALTR
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2024-11-13
09:04 am
Unchanged
2024-11-1313GAdaptimmune Therapeutics plc
ADAP
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2024-11-13
09:00 am
Unchanged
2024-11-1313GAdaptive Biotechnologies Corporation
ADPT
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2024-02-13
4:15 pm
Unchanged
2024-02-1313GAltair Engineering Inc.
ALTR
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2023-11-09
4:34 pm
Unchanged
2023-11-0913DAura Biosciences, Inc.
AURA
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2023-07-10
4:15 pm
Unchanged
2023-07-1013GAdaptimmune Therapeutics plc
ADAP
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2023-06-20
4:30 pm
Unchanged
2023-06-2013DZentalis Pharmaceuticals, Inc.
ZNTL
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2023-02-13
4:07 pm
Unchanged
2023-02-1313GNew Relic, Inc.
NEWR
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2023-02-13
4:06 pm
Unchanged
2023-02-1313GForgeRock, Inc.
FORG
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2023-02-13
4:05 pm
Unchanged
2023-02-1313GAltair Engineering Inc.
ALTR
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
2023-02-13
4:04 pm
Unchanged
2023-02-1313GPerimeter Solutions, S.A.
PRM
Matrix Capital Management Company LP0
0.000%
0
(Unchanged)
Filing
Goto 0, 1, Next